ArticleBritish journal of cancer2023

Increased cross-presentation by dendritic cells and enhanced anti-tumour therapy using the Arp2/3 inhibitor CK666.

Mariana M S Oliveira et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.